Evaluation of the Performance and Safety of the Aktiia Spot-check Optical Blood Pressure Monitoring (OBPM) Device at Fingertip (Aktiia G2C) Against Double Auscultation, and Comparison With Oscillometry and Aktiia Bracelet G2 - Trial NCT06368206
Access comprehensive clinical trial information for NCT06368206 through Pure Global AI's free database. This phase not specified trial is sponsored by Aktiia SA and is currently Not yet recruiting. The study focuses on Hypertension. Target enrollment is 85 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Aktiia SA
Timeline & Enrollment
N/A
May 15, 2024
Dec 31, 2024
Primary Outcome
Blood pressure mean value of differences,Blood pressure standard deviation of differences
Summary
The present study, OBPM_Calfree2024, with N = 85 participants minimum over 1 visit (lasting
 around 1h), has been designed to evaluate the performances and safety of the
 Aktiia.product-G2C that doesn't require any calibrations, as compared against double
 auscultation for BP reference measurements, and finger pulse oximeter for pulse rate
 reference measurements, for a cohort of subjects characterized by a wide variety of
 phenotypes.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06368206
Device Trial